The Single Cancer Pathway
|
|
- Miles Merritt
- 5 years ago
- Views:
Transcription
1 The Single Cancer Pathway
2 Background and Case for Change
3 Case for Change (1) Broadly patient experience of cancer services in Wales is good: 93% of patients rate their care as 7/10 or better (WPES) But survival compared to other developed countries is poor (ICBP)
4 The consistency of this finding suggests this is less related to use of treatment but the way the system is working (ICBP, Eurocare, Concorde) Five year relative survival rate comparisons for Wales 5-year-age-standardised relative survival for adult patients with cancer, diagnosed De Angelis R, Sant M, Coleman MP, et al. Cancer survival in Europe by country and age: results of EUROCARE-5 a population-based study. The Lancet Oncology 2013
5 International Cancer Benchmarking Partnership Module 1: Inferior survival likely related in part to late stage presentation (1 year survival surrogate for stage at presentation)
6 International Cancer Benchmarking Partnership Module 3: GPs in Wales less likely to refer and/or investigate for a given set of signs and symptoms This correlated with worse survival
7 International Cancer Benchmarking Partnership Module 4: After presentation patients in Wales spend longer in healthcare system before starting treatment than other countries/jurisdictions
8 State of Diagnostic Services in Wales 9-10% increase in CT, MR, Endoscopy year on year 10-50% posts vacant in Wales, all HBs outsourcing 30% of workforce could retire in next 5 years >50% current workforce >10 (many >12), unable to attract trainees, <50% primary care timely direct access to NICE recommended diagnostics 7 radiologists per 100, 000 compared to European average CT scanners per million, compared with 35 in Denmark Situation similar or worse across primary care and pathology
9
10
11 Case of Mr Jones 72 year old previously fit male t0 PS 0 DG 1 72Kg Noticed food sticking in October 17, saw GP, prescribed PPI Rapid access OGD Jan, malignant stricture lower oesophagus Referred to Upper GI team (nusc), seen within 2 weeks CT scan and local MDT 2 weeks EUS (Carmarthen) and PET 3 weeks CPEX in further 2 weeks MDT 10 days after PET, T4N1M0 cancer, refer to oncology Seen within 2 weeks, unable to swallow, referred for a stent t90 PS 1 DG2 68Kg t120 PS 2 DG 3 64Kg
12
13 April 2012 May 2012 June 2012 July 2012 August 2012 September 2012 October 2012 November 2012 December 2012 January 2013 February 2013 March 2013 April 2013 May 2013 June 2013 July 2013 August 2013 September 2013 October 2013 November 2013 December 2013 January 2014 February 2014 March 2014 April 2014 May 2014 June 2014 July 2014 August 2014 September 2014 October 2014 November 2014 December 2014 January 2015 February 2015 March 2015 April 2015 May 2015 June 2015 July 2015 August 2015 September 2015 October 2015 November 2015 December 2015 January 2016 February 2016 March 2016 April 2016 May 2016 June 2016 July 2016 August 2016 September 2016 October 2016 November 2016 December 2016 January 2017 February 2017 March 2017 April 2017 May 2017 June 2017 July 2017 August 2017 September 2017 October 2017 November 2017 December 2017 Percentage of people starting treatment within 62 days of referral Percentage of people USC 62 day performance (%) against target in Wales over last 5 years nusc 31 day performance (%) against target in Wales over last 5 years Percent Percentage of people starting treatment within 62 days of USC referral in Wales Apr Dec 2017 Percentage of people starting treatment within 31 days of agreeing their plan for all cancer sites in Wales % 90% 80% 95% 86% 100% 98% 98% 70% 96% 60% 94% 50% 92% 40% 30% 90% 20% 88% 10% 86% 0% 84% 82% Month 80% Year Wales Target
14 Variation in the System
15 Conversion rates for all cancers by HB in 2017 Detection rates for all cancers by HB in 2017 Conversion Rate for all cancer sites by health board for 2017 Detection Rate for all cancer sites by health board for % 60% 54.1% 10.0% 8.0% 6.9% 10.2% 7.4% 7.4% 8.2% 8.5% 7.9% 50% 40% 45.3% 44.2% 47.1% 33.1% 44.1% 44.8% 6.0% 30% 4.0% 20% 2.0% 10% 0.0% Betsi Cadwaladr University Health Board Hywel Dda University Health Board Abertawe Bro Morgannwg University Health Board Cwm Taf University Health Board Aneurin Bevan University Health Board Cardiff and Vale University Health Board Wales 0% Betsi Cadwaladr University Health Board Hywel Dda University Health Board Abertawe Bro Morgannwg University Health Board Cwm Taf University Health Board Aneurin Bevan University Health Board Cardiff and Vale University Health Board Wales
16 Conversion Rate Detection Rate Conversion rates for all UGI cancers by HB in 2017 Detection rates for all UGI cancers by HB in % USC Conversion rate for Upper Gastrointestinal Cancer by Health Board for 2017 Detection Rate of Cancer via USC pathway by Health Board for 2017 Upper Gastrointestinal Cancer 9% 8.5% 70% 8% 60% 58.4% 7% 6% 5% 4% 3.7% 5.9% 3.4% 4.3% 4.2% 50% 40% 30% 41.4% 35.7% 36.0% 34.3% 35.1% 3% 20% 2% 1% 1.7% 10% 11.1% 0% Betsi Cadwaladr University Health Board Hywel Dda University Health Board Abertawe Bro Morgannwg University Health Board Cwm Taf University Health Board Health board Aneurin Bevan University Health Board Cardiff and Vale University Health Board Wales 0% Betsi Cadwaladr University Health Board Hywel Dda University Health Board Abertawe Bro Morgannwg University Health Board Cwm Taf University Health Board Cancer Site Aneurin Bevan University Health Board Cardiff and Vale University Health Board Wales
17 Conversion Rate Detection Rate USC conversion rates by cancer site in 2017 Detection rates by cancer site in % USC Conversion rate for all Wales by Cancer Site for 2017 Detection Rate of Cancer via USC pathway by Cancer Site for all Wales for % 20% 19.8% 50% 46.6% 52.2% 15% 15.2% 40% 35.1% 37.0% 37.1% 30% 10% 7.9% 20% 5% 4.2% 4.7% 10% 0% Upper Gastrointestinal Lower Gastrointestinal Lung Breast Urological Cancer site 0% Upper Gastrointestinal Lower Gastrointestinal Lung Breast Urological Cancer Site
18 The Single Cancer Pathway
19 Percentage of people Percentage of people starting treatment in 62 days from referral Cancer Waiting Times (in Wales but similar to England) 100% 90% Percentage of people starting treatment within 62 days of USC referral for all cancer site groups in Wales % 80% 62 day pathway for Urgent Suspected Cancer (USC) primary care referrals from receipt of referral Performance Wales ~ 85-90% 70% 60% 50% 40% 30% 20% 10% 0% Wales Target Percentage of people starting treatment within 31 days of agreeing their plan for all cancer sites in Wales % 31 day pathway for non USC from point patient agrees treatment plan Performance Wales ~ 95-98% 98% 96% 94% 92% 90% 98% 88% 86% 84% 82% 80% Year Wales Target
20 USC Pathway 62 day pathway Day 0 Day 62 Point of Suspicion (PoS) Referral Diagnosis Date of Decision to Treat Treatment Time NOT currently captured by CWT ~35-45% of cancers diagnosed via USC pathway Time in system NOT currently captured by CWT ~55-65% of cancers identified via non-usc pathway Key: - These waits will be exposed under the proposed SCP reporting Non-USC Pathway 31 day pathway
21 Days Patient 1 - Dec-13 Patient 4 - Nov-15 Patient 7 - May-16 Patient 10 - Aug-16 Patient 13 - Sep-16 Patient 16 - Nov-16 Patient 19 - Dec-16 Patient 22 - Jan-17 Patient 25 - Jan-17 Patient 28 - Jan-17 Patient 31 - Feb-17 Patient 34 - Mar-17 Patient 37 - Mar-17 Patient 40 - Mar-17 Patient 43 - Apr-17 Patient 46 - Jun-17 Patient 49 - Jul-17 Patient 52 - Jul-17 Patient 55 - Sep-17 Patient 58 - Sep-17 Patient 61 - Oct-17 Patient 64 - Oct-17 Patient 67 - Nov-17 Patient 70 - Dec-17 Cancer Waiting Times (in Wales but similar to England) Average 70 Median 65 95th Percentile The majority (~55-65%) of cancer patients are diagnosed via the nusc pathway Approximately 50% of patients on complex pathways wait > 62 days on nusc pathway from point of suspicion This reporting of this CWT does not reflect patient experience, does not reflect diagnostic capacity challenges and does not drive pathway improvement OGD to Rx Median Expected Actual Patient Waiting times for UGI patients from Point of Suspicion i.e. OGD
22 Percentage USC CWT performance by HB & Cancer Site Sept Dec % 90% 80% 70% 60% 50% 40% 30% 20% 10% 0% 88% Percentage of people starting treatment within 62 days of USC referral for all cancer site groups by health board for Sept - Dec % Betsi Cadwaladr Hywel Dda University University Health Board Health Board 86% Abertawe Bro Morgannwg University Health Board 89% 89% 89% 88% Cwm Taf University Health Board Aneurin Bevan Cardiff and Vale University Health Board University Health Board Wales 100% 90% 80% 70% 60% 50% 40% 30% 20% 10% 0% Percentage of people starting treatment within 62 days of USC referral by Cancer Site in Wales Sept - Dec % 75% Upper Gastrointestinal Lower Gastrointestinal Lung Breast Urological 89% Cancer Site Group 94% 89%
23 April 2012 May 2012 June 2012 July 2012 August 2012 September 2012 October 2012 November 2012 December 2012 January 2013 February 2013 March 2013 April 2013 May 2013 June 2013 July 2013 August 2013 September 2013 October 2013 November 2013 December 2013 January 2014 February 2014 March 2014 April 2014 May 2014 June 2014 July 2014 August 2014 September 2014 October 2014 November 2014 December 2014 January 2015 February 2015 March 2015 April 2015 May 2015 June 2015 July 2015 August 2015 September 2015 October 2015 November 2015 December 2015 January 2016 February 2016 March 2016 April 2016 May 2016 June 2016 July 2016 August 2016 September 2016 October 2016 November 2016 December 2016 January 2017 February 2017 March 2017 April 2017 May 2017 June 2017 July 2017 August 2017 September 2017 October 2017 November 2017 December 2017 USC Referrals USC Referrals Numbers of Total USC referrals in Wales Number of USC Referrals in Wales by year between Jan Dec 2017 Measure Number of USC Referrals in Wales by month between April December Year Month
24 USC Referrals USC Referrals UGI numbers USC numbers treated UGI within time per quarter Sept Dec Run Chart: Number of USC Referrals in Wales by year between Jan Dec 2017 Upper Gastronintestinal 100% Percentage of people starting treatment within 62 days of USC referral for Sept - Dec 2017 Upper Gastrointestinal 100% Median % 80% 70% 88% 86% 72% 67% 69% 79% % 50% % % 20% 0 10% Year 0% Betsi Cadwaladr University Health Board Hywel Dda University Health Board Abertawe Bro Morgannwg University Health Board Cwm Taf University Health Board Aneurin Bevan University Health Board Cardiff and Vale University Health Board Wales
25 USC Referrals USC Referrals USC Referrals numbers UGI & LGI Run Chart: Number of USC Referrals in Wales by year between Jan Dec 2017 Upper Gastronintestinal Run Chart: Number of USC Referrals in Wales by year between Jan Dec 2017 Lower Gastronintestinal Median Median Year Year
26 Ministerial and CIG response Pressure on system to comply with current CWT targets 2015 asked for clinical review of CWT targets Clinical view Waiting times important for patients and clinicians System should work better and 62 days max time Not in favour of exclusions 2016/17 WG/Network response Pilot new suspected cancer (SC) pathway starting at PoS (where nec as defined by NG12) Pilot suggested 20% increased demand in diagnostics but requirement for improved pathways and not including required increase for NG12 Autumn 2017 Cabinet secretary indicated support for move to SCP Urged NHS Wales to prepare to be compliant with a 62 day SCP target
27 Summary Patients have relatively poor survival in Wales with stage at diagnosis a key factor in this Patients are waiting too long in the healthcare system before receiving treatment The current system of CWT reports contains hidden waits, does not reflect patient experience, does not report inadequate diagnostic and treatment capacity and does not drive improvement CEOs, Chairs, CIG, CSG, WCN, HB/Trusts agree: A single suspected cancer pathway that reports waiting times for all patients from the point of suspicion is.. THE RIGHT THING TO DO The benefits should lead to better patient outcomes (survival, experience), better patient support and less costly treatment No one underestimates the challenge but we must work together, share best practice and be open to change
28 Achievements to Date Briefing document for Cab Sec and CEOs Suite of best practice Peer review of HB SCP Plans 8 site specific optimum pathways Received and reviewed HB Implementation Plans Worked with NWIS to define PoS, impact assessment for DSCN Worked with DU to determine capacity and demand model Worked with 1000 lines re improvement approach and 5 workshops Meetings with Cab Sec and WG
29 Plans Meeting with CEOs, Chairs and Cab Sec Oct 22 nd Submit advice re requirement for increased funding for diagnostics and national SCP Programme HB to use C&D to inform IMTPs (meet current gap and forecast demand) Q Implement new Tracker 7 and embed in HB PAS systems by May 2019 Likely to publish SCP performance from April/May 2019 Continuous improvement work in 2019? 95% compliance by April 2020
30 SCP Performance
31 SCP Upper GI overall monthly average Apr 17-Dec 17 by HB 70%
32 SCP Lower GI overall monthly average Apr 17-Dec 17 by HB 58% 65% 55% 59% 54% 69%
33 SCP Urology overall monthly average Apr 17-Dec 17 - by HB
34 SCP Lung overall monthly average Apr 17-Dec 17 by HB 70% 75% 74% 71% 71% 59%
35 SCP Gynaecology overall monthly average Apr 17- Dec 17 by HB 70% 54% 50% 50% 57% 24%
36 SCP Head & Neck overall monthly average Apr 17-Dec 17 by HB 80% 76% 70% 60% 54% 57% 63% 57% 50% 45% 40% 30% 20% 10% 0% AB ABMU BCU CT C&V HD
37 SCP Breast overall monthly average Apr 17-Dec % 90% 87% 94% 96% 86% 96% 80% 70% 72% 60% 50% 40% 30% 20% 10% 0% AB ABMU BCU CT C&V HD
38 New rules.. Single Suspected Cancer Pathway Definitions pathway start date Date: March 2018 Version: Wales Cancer Owner: Network and Welsh Government Status Published
39 How do we do this? Best Practice Principles Implementing enabling systems and infrastructure Standardising and improving the whole patient pathway Point of suspicion Tracking Information and Intelligence Capacity and Demand Pathway Improvement Referral/Primary Care PoS to Last Diagnostic <28days DDT to Treatment < 21 days Clinical Engagement Patient Centred Care
40 Work streams Information and Intelligence Capacity & Demand Communication Primary Care Diagnostic Pathway Treatment Pathway CSG s and Clinical Engagement Patient Centred Care Improvement
41 Priorities To understand the additional capacity required for the NHS to be able to treat all patients from the PoS within 62 days or 95% of patients to be diagnosed and staged < 28 days and treated < 21 days from decision to treat To understand where capacity required eg OPA, imaging, endoscopy, treatment Understand whether increased capacity due to rising referrals, improved USC performance or accelerated nusc pathway To standardise pathways across Wales consistently using best practice principles such as use of NG12 and entry points into system eg straight to test
42 Priorities To establish informatics systems to link with HB PAS systems that can receive e-referrals, can be easily started on clinical suspicion of cancer, can make system aware patient on accelerated pathway, track patient and record component and total waiting times To understand better where support systems should be introduced eg patient information, prehabilitation, holistic needs support and research To undertake a set of improvement workshops within HBs and across boundaries in Cancer Site Groups to reduce delays due to decision making in MDTs or weekly clinics or introduce accelerated steps such as same day/next day to CT from endoscopy or CXR
43 Priorities To establish a set of local and National reports that highlight variation between HBs and Cancer Sites and specific pathway steps, to understand the causes of this variation and share best practice across Wales To compare and contrast HB SCP Delivery Plans to help a local and National understanding of what required to achieve compliance with an SCP (assuming 95% compliance with 62 day target)
44
45
46 Summary Patients have relatively poor survival in Wales with stage at diagnosis a key factor in this Patients are waiting too long in the healthcare system before receiving treatment The current system of CWT reports contains hidden waits, does not reflect patient experience, does not report inadequate diagnostic and treatment capacity and does not drive improvement CEOs, Chairs, CIG, CSG, WCN, HB/Trusts agree: A single suspected cancer pathway that reports waiting times for all patients from the point of suspicion is.. THE RIGHT THING TO DO!
47 Summary The benefits should lead to better patient outcomes (survival, experience), better patient support and less costly treatment Benefits beyond accelerated pathway, more structured and standardised pathways allow for better information and holistic support, access to research and capacity/demand modelling No one underestimates the challenge but NHS Wales, WG, 3 rd sector and cancer services stakeholders are working together, sharing best practice and are open to change
Briefing Paper. Single Cancer Pathway
Briefing Paper Single Cancer Pathway Author: Tom Crosby, Clinical Director, Wales Cancer Network Owner: Wales Cancer Network Date: 27 th November 2017 Version: 1.0 Publication/ Distribution: Wales Cancer
More informationCIG SCP Health Board/Velindre Implementation Plan (Aneurin Bevan University Health Board)
CIG SCP Health Board/Velindre Implementation Plan (Aneurin Bevan University Health Board) 1 Governance, Leadership and Planning a) Describe your SCP Programme Board (or equivalent), its membership and
More informationClostridium difficile (C. difficile) and Staphylococcus aureus bacteraemia (MRSA and MSSA) Bi-annual Report. Surveillance: Report:
Surveillance: Report: Clostridium difficile (C. difficile) and Staphylococcus aureus ( and ) Bi-annual Report Time period: 1 st April to 30 th September 2016 Health Board: Wales Content: Issued by: Pg
More informationLung Cancer 2013 Peer Review All Wales Report
Lung Cancer 2013 Peer Review All Wales Report This publication and other HIW information can be provided in alternative formats or languages on request. There will be a short delay as alternative languages
More informationIn this edition: Newsletter Summer How Primary Care can help earlier diagnosis. Improving communication between Primary & Secondary Care
Newsletter Summer 2016 In this edition: How Primary Care can help earlier diagnosis Improving communication between Primary & Secondary Care A new approach to longer term care How primary care is adapting
More information8 Public Health Wales CDSC Weekly Influenza Surveillance Report Wednesday 21 August 2013 (covering week )
8 Public Health Wales CDSC Weekly Influenza Surveillance Report Wednesday 21 August 213 (covering week 33 213) Current level of activity: Low Trend: Stable compared to last week News: Update Middle East
More informationSingle Suspected Cancer Pathway Definitions pathway start date
Single Suspected Cancer Pathway Definitions pathway start date Date: March 2018 Version: 1.2.1 Wales Cancer Owner: Network and Welsh Government Status Published 1 P a g e Purpose of Document This document
More informationNHS WALES PRIMARY CARE PRESCRIBING ANALYSIS: TRAMADOL. April 2013
NHS WALES PRIMARY CARE PRESCRIBING ANALYSIS: TRAMADOL This report has been prepared by the Welsh Analytical Prescribing Support Unit (WAPSU), part of the All Wales Therapeutics and Toxicology Centre (AWTTC).
More informationNHS WALES PRIMARY CARE PRESCRIBING ANALYSIS FOR TRAMADOL DATA TO SEPTEMBER 2014
NHS WALES PRIMARY CARE PRESCRIBING ANALYSIS FOR TRAMADOL DATA TO SEPTEMBER 2014 March 2015 This report has been prepared by the Welsh Analytical Prescribing Support Unit (WAPSU), part of the All Wales
More informationWelsh Cardiovascular Society. Spring 2018
Welsh Cardiovascular Society Spring 2018 NHS Wales Atlas of Variation for Cardiovascular Disease Context In the NHS Wales Heart Conditions Delivery PlanJanuary 2017, unwarranted variation in practice
More informationBrighton and Sussex University Hospitals NHS Trust Board of Directors. Mark Smith Chief Operating Officer
Meeting: Brighton and Sussex University Hospitals NHS Trust Board of Directors Date: 24 th August 2015 Board Sponsor: Paper Author: Subject: Mark Smith Chief Operating Officer Clinical Director and Directorate
More informationWales Cancer Network. An Introduction to the Wales Cancer Network January Part of the NHS Wales Health Collaborative
Wales Cancer Network An Introduction to the Wales Cancer Network January 2019 Part of the NHS Wales Health Collaborative 2 Contents Page 3-4 1. About Us Page 4-6 2. Cancer Delivery Plan 2016-2020 Page
More informationWelsh Cancer Intelligence and Surveillance Unit Uned Gwybodaeth a Gwyliadwriaeth Canser Cymru
Cancer in Wales Incidence by stage at diagnosis 2011 to 2015 www.wcisu.wales.nhs.uk Latest available cancer incidence by stage at diagnosis official statistics for Wales for diagnosis years 2011 to 2015,
More informationStoryboard submission
Storyboard submission Follow the detailed instructions in this template for writing a description of your storyboard. Type your information in each section below and save this completed storyboard document
More informationTrust Board of Directors Public. Denise Gale. For Assurance and Information NOT APPLICABLE NOT APPLICABLE NOT APPLICABLE NOT APPLICABLE
NLG(18)014 DATE OF MEETING 30 January 2018 REPORT FOR Trust Board of Directors Public REPORT FROM Richard Sunley, Deputy Chief Executive CONTACT OFFICER Denise Gale SUBJECT Cancer Performance and Backlog
More informationSingle Suspected Cancer Pathway Definitions pathway start date
Single Suspected Cancer Pathway Definitions pathway start date Date: December 2018 Version: 8.0 Wales Cancer Owner: Network and Welsh Government Status Draft 1 P a g e Purpose of Document This document
More informationWales Primary Care COPD Audit
Wales Primary Care COPD Audit 2014-15 Next steps for improvement National Chronic Obstructive Pulmonary Disease (COPD) Audit Programme 2016 The audit programme partnership Working in strategic partnership:
More informationPublic Health Wales CDSC Weekly Influenza Surveillance Report Wednesday 21 st January 2015 (covering week )
The The Influenza B in certain countries8 Public Health Wales CDSC Weekly Influenza Surveillance Report Wednesday 21 st January 215 (covering week 3 215) Current level of activity: Low Trend: Decreased
More information2014/15 ANNUAL REPORT OF THE POWYS HEART DISEASE DELIVERY PLAN. Director of Public Health. Director of Public Health
BOARD MEETING 21 OCTOBER 2015 AGENDA ITEM 2.8 2014/15 ANNUAL REPORT OF THE POWYS HEART DISEASE DELIVERY PLAN Report of Director of Public Health Paper prepared by Director of Public Health Principal Health
More informationWHERE NEXT FOR CANCER SERVICES IN WALES? AN EVALUATION OF PRIORITIES TO IMPROVE PATIENT CARE
WHERE NEXT FOR CANCER SERVICES IN WALES? AN EVALUATION OF PRIORITIES TO IMPROVE PATIENT CARE EXECUTIVE SUMMARY Incidence of cancer is rising, with one in two people born after 1960 expected to be diagnosed
More informationHealth Board/Region: All-Wales
Peer Review: Cancer Sub-site: Gynaecology Health Board/Region: All-Wales Cycle: Second Date of review: February 2018 This report describes the findings and themes observed by clinical review panels during
More informationCancer Delivery Plan. Interim Progress Report
Cancer Delivery Plan Interim Progress Report Ref: ABMUHB Reporting Period: November 2012 March 2013 Highlights / Key Achievements PC1 PC2 - PC2.4 Director of Public Health (SH) agreed to become member
More informationKC53/61/65 Statistical Report Adroddiad Ystadegol 2012/13 Prepared by Cervical Screening Wales
KC53/61/65 Statistical Report Adroddiad Ystadegol 2012/13 Prepared by Cervical Screening Wales CERVICAL SCREENING WALES STATISTICAL REPORT CERVICAL SCREENING PROGRAMME, WALES: 2012/2013 For more information
More informationHealthier Communities. Effective Governance
Our Key Priorities Effective Governance Healthier Communities Accessible and sustainable services Our values Excellent outcomes and experience Strong partnerships A Fully Engaged and Skilled Workforce
More informationCommunity Pharmacy Influenza Vaccination A summary of the results of the national Community Pharmacy Seasonal Influenza Vaccination Service
Community Pharmacy Influenza Vaccination 2012-13 A summary of the results of the national Community Pharmacy Seasonal Influenza Vaccination Service Digital ISBN 978 0 7504 9511 0 Crown Copyright 2013 WG18824
More informationCancer Annual Report. Cwm Taf University Health Board. September 2014
Cancer Annual Report Cwm Taf University Health Board September 2014 1 CONTENTS PAGE 1.0 Executive summary 3 2.0 Introduction 5 3.0 Cancer Incidence, Mortality and Survival in CTUHB 7 4.0 Our approach to
More informationCancer Delivery Plan. April Abertawe Bro Morgannwg University Health Board
Cancer Delivery Plan 16 April Abertawe Bro Morgannwg University Health Board Page 1 of 15 1. Background and context Together for Health a Cancer Delivery Plan was published in 2012 and provides a framework
More informationNational Standards for Acute Oncology Services
Cancer National Specialist Advisory Group National Standards for Acute Oncology Services June 2016 TABLE OF CONTENTS 1. PURPOSE... 2 2. INTRODUCTION... 2 3. STRATEGIC CONTEXT... 4 4. SCOPE OF ACUTE ONCOLOGY
More informationAnnual statement of progress Liver Disease Delivery Plan May 2017
Annual statement of progress Liver Disease Delivery Plan May 2017 Overview Liver disease is the third most common cause of premature death in the UK and the national liver disease health outcomes are worse
More informationNational Optimal Lung Cancer Pathways. Dr Sadia Anwar Nottingham University Hospitals NHS Trust Clinical Lead for Lung Cancer
National Optimal Lung Cancer Pathways Dr Sadia Anwar ttingham University Hospitals NHS Trust Clinical Lead for Lung Cancer Overview How NOLCP evolved How it relates to national guidance Pathways Implementation
More informationFaster Cancer Treatment: Using a health target as the platform for delivering sustainable system changes
Faster Cancer Treatment: Using a health target as the platform for delivering sustainable system changes Organisation Name: Ko Awatea, Counties Manukau Health Presenter: Bob Diepeveen HRT 1520 Innovations
More informationPICTURE OF ORAL HEALTH 2012 DENTAL EPIDEMIOLOGICAL SURVEY OF 5 YEAR OLDS
PICTURE OF ORAL HEALTH 2012 DENTAL EPIDEMIOLOGICAL SURVEY OF 5 YEAR OLDS 2011-12 1 Contents Page Number Summary Introduction Preventable decay in Wales Preventable decay in Local Health Boards Preventable
More informationUptake of pertussis and influenza vaccination in pregnant women in Wales
Vaccine Preventable Disease Programme Uptake of pertussis and influenza vaccination in pregnant women in Wales 2013-14 Authors: Anne McGowan, Richard Lewis, Richard Roberts, Simon Cottrell. Vaccine Preventable
More informationQuality & Safety Committee Date: 22 June 2016 Agenda item: 4.4
SUMMARY REPORT ABM University Health Board Quality & Safety Committee Date: 22 June 20 Agenda item: 4.4 Subject Prepared by Approved by Infection Prevention & Control Delyth Davies, Head of Nursing, Infection
More informationDeath and dying in Wales
Death and dying in Wales An analysis of inconsistencies in access to specialist palliative care and hospital activity in the last year of life Marie Curie Cancer Care and the Bevan Foundation December
More informationNational Prescribing Indicators Analysis of Prescribing Data to September 2015
National Prescribing Indicators 2016 Analysis of Prescribing Data to tember National Prescribing Indicators 2016. Analysis of Prescribing Data to tember EXECUTIVE SUMMARY The All Wales Medicines Strategy
More informationCancer Alliance Data Pack
Humber, Coast and Vale Cancer Alliance Data Pack By February 18 Version 1.2 Produced by the Cancer Alliance Data, Evidence and Analysis Service (CADEAS) For any enquiries contact: england.cadeas@nhs.net
More informationMDT IMPROVEMENT PROJECT. Professor Muntzer Mughal, UCLH
MDT IMPROVEMENT PROJECT Professor Muntzer Mughal, UCLH 1995..assessment and management of rare cancers in multidisciplinary teams.. 2000 the care of all patients with cancer should be formally reviewed
More informationRTT Exception Report
Appendix 3 RTT Exception Report 1. Purpose To provide a summary of factors impacting on 18 week RTT performance and a revised forecast of red rated performance for Quarter 2 2015/16 for the admitted pathway.
More informationCancer Services Position & Recovery Plan June 2015
Appendix 6 Cancer Services Position & Recovery Plan June 2015 Introduction The Trust is required to achieve 85% compliance for patients on a 62 day pathway from the referral date to the date they receive
More informationNational COPD Audit Programme
National COPD Audit Programme Planning for every breath Primary Care Audit (Wales) 2015-17 Findings and quality improvement The audit programme partnership Working in strategic partnership: Supported by:
More informationHealth Board/Region: Cardiff & Vale University Health Board Main Hospital Base: University Hospital of Wales, Llandough. Date of review: 28 June 2018
Peer Review: Cancer Sub-site: Breast Health Board/Region: Cardiff & Vale University Health Board Main Hospital Base: University Hospital of Wales, Llandough Cycle: Second Date of review: 28 June 2018 REVIEWEES
More informationSouth West Cancer Alliances Rapid Diagnostic Pathway for Lung Cancer Project Evaluation
Somerset, Wiltshire, Avon and Gloucestershire Cancer Alliance Peninsula Cancer Alliance South West Cancer Alliances Rapid Diagnostic Pathway for Lung Cancer Project Evaluation Peninsula Thoracic-Oncology
More informationACTION PLAN FOLLOWING THE LUNG CANCER PEER REVIEW
ACTION PLAN FOLLOWING THE LUNG CANCER PEER REVIEW Health Board: Named Health Board contact: Cancer Network: Named contact for Cancer Network: Health Inspectorate Wales contact: Abertawe Bro Morgannwg University
More informationCancer Waiting Times in NHSScotland
Publication Report Cancer Waiting Times in NHSScotland 1 April to 30 June 2017 Publication date 26 September 2017 A National Statistics Publication for Scotland Contents Introduction... 3 Main points...
More informationHIGH BLOOD PRESSURE. How can we do better?
HIGH BLOOD PRESSURE How can we do better? Review date: February 2018 This publication includes practical guidance from GPs, nurses and pharmacists on how you can improve detection and management of high
More informationWelsh Cancer Intelligence and Surveillance Unit, Public Health Wales
1 Project team Rebecca Thomas, Tamsin Long, Gareth Davies and Martin Holloway Reference group Ceri White, Helen Crowther, Joan Wilding, Karen Gully, Siôn Edwards, Richard Neal, Sean Young, John Lucy, Anne
More informationWHERE NEXT FOR CANCER SERVICES IN NORTHERN IRELAND? AN EVALUATION OF PRIORITIES TO IMPROVE PATIENT CARE
WHERE NEXT FOR CANCER SERVICES IN NORTHERN IRELAND? AN EVALUATION OF PRIORITIES TO IMPROVE PATIENT CARE EXECUTIVE SUMMARY Incidence of cancer is rising, with one in two people born after 1960 expected
More informationTrust Board Meeting in Public: Wednesday 11 July 2018 TB
Trust Board Meeting in Public: Wednesday 11 July 2018 Title Integrated Performance Report: Month 2 Status History For information. The report provides a summary of the Trust s performance against a range
More informationCancer Waiting Times in NHSScotland
Cancer Waiting Times in NHSScotland 1 October to 31 December 2017 Publication date 27 March 2018 A National Statistics publication for Scotland This is a National Statistics Publication National Statistics
More informationWEDINOS Headlines 6,452. wedinos.org 5,806 BULLETIN. Samples. received. Samples. received. Samples. analysed. Samples. rejected
BULLETIN Issue 11 - Jan - Mar 2017 WEDINOS Quarterly Newsletter Collecting, Testing, Informing wedinos.org WEDINOS Headlines TOTAL number of samples received by WEDINOS October 2013 to March 2017 The WEDINOS
More informationSeasonal influenza in Wales 2016/17
Much Seasonal influenza in Wales 2016/17 Annual Report Page 1 of 53 Summary The 2016/17 influenza season in Wales arrived and peaked earlier than the previous two seasons and reached moderate levels. Influenza
More informationCancer Delivery Plan. October Abertawe Bro Morgannwg University Health Board
Cancer Delivery Plan 2016 17 October 2016 Abertawe Bro Morgannwg University Health Board 1 1. Background and context Together for Health a Cancer Delivery Plan was published in 2012 and provides a framework
More informationCancer Alliance Data Pack
Surrey and Sussex Cancer Alliance Data Pack By February 18 Version 1.1 Produced by the Cancer Alliance Data, Evidence and Analysis Service (CADEAS) For any enquiries contact: england.cadeas@nhs.net Contents
More informationThe Infection Control Doctor and Clostridium difficile infection. Dr David R Jenkins University Hospitals of Leicester NHS Trust, England
The Infection Control Doctor and Clostridium difficile infection Dr David R Jenkins University Hospitals of Leicester NHS Trust, England 250 200 150 100 50 0 Monthly cases of Clostridium difficile (UHL
More informationCancer Waiting Times in NHSScotland
Publication Report Cancer Waiting Times in NHSScotland 1 July to 30 September 2017 Publication date 12 December 2017 A National Statistics Publication for Scotland Contents Introduction... 3 Main points...
More informationStreamlining the lung diagnostic pathway (A87)
Streamlining the lung diagnostic pathway (A87) Crawley CCG with Surrey and Sussex Healthcare NHS Trust Evaluation January 2017 Summary A new Straight-to-CT pathway for patients with an abnormal CXR result
More informationPersistent Pain Resources. Educational Slide Set
Persistent Pain Resources Educational Slide Set October 216 This document has been prepared by a multiprofessional collaborative group, with support from the All Wales Prescribing Advisory Group (AWPAG)
More informationACTION PLAN FOLLOWING THE LUNG CANCER PEER REVIEW
ACTION PLAN FOLLOWING THE LUNG CANCER PEER REVIEW Health Board: Named Health Board contact: Cancer Network: Named contact for Cancer Network: Health Inspectorate Wales contact: Abertawe Bro Morgannwg University
More informationIntegrated Cancer Services Action Plan. Colchester Hospital University NHS Foundation Trust 31 March 2014
Integrated Cancer Services Action Plan Colchester Hospital University NHS Foundation Trust 31 March KEY Implemented, clearly evidenced and externally approved On Track to deliver Some issues narrative
More informationSeasonal influenza in Wales /15
Seasonal influenza in Wales - 2014/15 Annual Report Page 1 of 43 Summary Taking into account information from all influenza surveillance indicators, the 2014/15 influenza season in Wales saw moderate levels
More informationIAPT Performance Workshop
IAPT Performance Workshop May 2015 Els Drewek Head of Intensive Support) England (els.drewek @nhs.net) 1 This set of slides is provided in support of the interactive workshop on IAPT Performance and will
More informationDon t let falls get you down
19 February 2013 Don t let falls get you down Dr Sarah J Jones, Consultant, Environmental Health Protection, Public Health Wales Insert name of presentation on Master Slide Structure Epidemiology Evidence
More informationHas the UK had a double epidemic?
Has the UK had a double epidemic? Dr Rodney P Jones Healthcare Analysis & Forecasting www.hcaf.biz hcaf_rod@yahoo.co.uk Introduction Outbreaks of a new type of epidemic, possibly due to immune manipulation,
More informationReport on Population based National Screening Programmes in Abertawe Bro Morgannwg University Health Board
Report on Population based National Screening Programmes in Abertawe Bro Morgannwg Author: Kimberley Cann, Specialty Registrar in Public Health, Dr Sikha de Souza, Locum Consultant and Dr Sharon Hillier,
More informationwedinos.org WEDINOS Headlines 6,056 Synthetic Cannabinoid Receptor Agonists and the Law 5,058
BULLETIN Issue 10 - Oct - Dec 2016 WEDINOS Quarterly Newsletter Collecting, Testing, Informing wedinos.org WEDINOS Headlines TOTAL number of samples received by WEDINOS October 2013 to December 2016 The
More informationSouth Norfolk CCG Dementia Strategy and Action Plan Dr Tony Palframan, SNCCG Governing Body Member
Agenda item: 9.4 Subject: Presented by: Submitted to: South Norfolk CCG Dementia Strategy and Action Plan Dr Tony Palframan, SNCCG Governing Body Member Governing Body Date: 28 th July Purpose of paper:
More informationWELSH HEALTH CIRCULAR
WHC (2017) Number 23 WELSH HEALTH CIRCULAR Issue Date: 16 June 2017 STATUS: ACTION CATEGORY: POLICY Title: Re-focussing of the Designed to Smile child oral health improvement programme Date of Expiry /
More informationTRANSFORM CANCER SERVICES
WORKING TOGETHER to TRANSFORM CANCER SERVICES in SOUTH EAST WALES 1 Understanding the context Cancer survival rates are increasing. But the number of people getting cancer is increasing too. At Velindre
More informationEnhanced pharmacy service assessment: weight management
Enhanced pharmacy service assessment: weight management Date: 05112009 Status: Final Intended Audience: Version: 1a Directors of pharmacy (or equivalent), health boards in Wales. Purpose and summary of
More informationImproving Oral Health Together
Improving Oral Health Together An Oral Health and Dental Service Improvement Plan for Abertawe Bro Morgannwg University Health Board Reducing Inn Oral Reduced inequities A five year vision Contents: Foreword
More information18 Week 92% Open Pathway Recovery Plan and Backlog Clearance
18 Week 92% Open Pathway Recovery Plan and Backlog Clearance Page 1 of 6 17.05.2012 1.0 Background 18-Week 92% Open Pathway RECOVERY PLAN The Trust has achieved compliance against the admitted and non-admitted
More informationNational Lymphoedema Strategy Programme. End of Year Report 2012/13 and Work Programme for 2013/14. Fiona Jenkins /Jane Fitzpatrick / Melanie Thomas
National Lymphoedema Strategy Programme End of Year Report 2012/13 and Work Programme for 2013/14 Sponsoring division: Contact: Who will present: Public Health and Health Professions Christopher Dawson
More informationCancer Improvement Plan Update. September 2014
Cancer Improvement Plan Update September 2014 1 Contents Page 1. Introduction 3 2. Key Achievements 4-5 3. Update on Independent Review Recommendations 6-13 4. Update on IST Recommendations 14-15 5. Update
More informationAneurin Bevan Health Board. Measles Emergency Response
Measles Emergency Response 1. Introduction The purpose of this paper is to inform the Board of the Measles Emergency Response measures and the work underway to try to prevent an epidemic of measles in
More informationAneurin Bevan Health Board. Screening Programmes
Aneurin Bevan Health Board Screening Programmes 1 Introduction The purpose of this report is to inform Board Members of the screening services offered nationally by Screening Services, Public Health Wales
More informationAHP Musculoskeletal Service Redesign. Judith Reid MSc MMACP Consultant Physiotherapist in MSK NHS Ayrshire and Arran
AHP Musculoskeletal Service Redesign Judith Reid MSc MMACP Consultant Physiotherapist in MSK NHS Ayrshire and Arran Local Drivers Routine referral practice Via acute care, duplication Long waiting times
More informationNational Cancer Programme. Work Plan 2015/16
National Cancer Programme Work Plan 2015/16 Citation: Ministry of Health. 2015. National Cancer Programme: Work plan 2015/16. Wellington: Ministry of Health. Published in October 2015 by the Ministry of
More informationEnd of Life Annual Report. Betsi Cadwaladr University Health Board. July 2015
End of Life Annual Report Betsi Cadwaladr University Health Board July 2015 1.0 Summary Across Wales, for our population we want the best services possible for those at the end of life. Palliative and
More informationImpact of cancer symptom awareness campaigns on diagnostic testing and treatment
Impact of cancer symptom awareness campaigns on diagnostic testing and treatment Abigail Bentley, Erika Denton, Lucy Ironmonger, Sean Duffy September 2014 Content Background Methods Key results Discussion
More informationBreast Screening Data Stephen Scott Head of Informatics LCA
Breast Screening Data Stephen Scott Head of Informatics LCA stephenscott@nhs.net The London Cancer Alliance Overview 62 day screening to 1 st treatment performance Key surgical measures monitored by LCA
More informationAn Updated Approach to Colon Cancer Screening and Prevention
An Updated Approach to Colon Cancer Screening and Prevention Kevin Liebovich, MD Director for Quality for Gastrointestinal diseases Advocate Condell Medical Center Colon Cancer Screening and Prevention
More informationOCCG Board Meeting. Oxfordshire Clinical Commissioning Group. Date of Meeting: 30 November 2017 Paper No: 17/80
OCCG Board Meeting Oxfordshire Clinical Commissioning Group Date of Meeting: 30 November 2017 Paper No: 17/80 Title of Paper: SCAN Pathway Project Update Paper is for: (please delete tick as appropriate)
More informationLeeds: Early Diagnosis Project updates
Leeds: Early Diagnosis Project updates Cancer Cascade Event, 11 th May 2017 Joanna Bayton-Smith, Macmillan Leeds Cancer Strategy, Programme Manager Objectives: To provide overview of Leeds Cancer Strategy
More informationWales Abdominal Aortic Aneurysm Screening Programme Proposal Paper: The Implementation and Development of Elective Vascular Networks
Wales Abdominal Aortic Aneurysm Screening Programme Proposal Paper: The Implementation and Development of Elective Vascular Networks Authors: Mr Rhys Blake; Mrs Llywela Wilson; Dr Rosemary Fox; Dr Gareth
More informationEast London Community Kidney Service
East London Community Kidney Service Sally Hull, Neil Ashman, Sec Hoong, Nicola Thomas, Helen Rainey April 2017 Haemodialysis/million population What is the Problem? Fast rising ESRD rates in East London
More informationCT Colon Service & Radiology Pathways
CT Colon Service & Radiology Pathways Louisa Edwards CT Colon Advanced Radiography Practitioner ABMU 6 th February 2019 Louisa.Edwards@wales.nhs.uk CT, Radiology Dept, POWH, ABMU Health Board Context and
More informationMonitoring Protocol for Clozapine-induced Myocarditis. Copyright 2017, CAMH
1 Monitoring Protocol for Clozapine-induced Myocarditis 1 Agenda Problem Identification / Identification Importance / Importance Baseline Workflow Baseline Workflow Baseline Data Baseline Data Objectives
More informationThere are a number of national guidelines and performance standards which support the implementation of a straight to CT pathway.
December 2015 CONTENTS Contents... 2 1 Introduction... 3 2 Case for Change... 3 3 Evidence... 3 3.1 National and regional policy... 3 3.2 Local audit... 4 4 Supporting Work Initiatives... 5 4.1 Identification
More informationUpper GI Cancer Network Site-Specific Group. Work Programme/Service Delivery Plan 2011/14
Upper GI Cancer Network Site-Specific Group Work Programme/Service Delivery Plan 2011/14 1 UPPER GI NSSG Work Programme/Service Delivery Plan AGREEMENT COVER SHEET 2011/14 This Work Programme has been
More informationCancer Annual Report. Abertawe Bro Morgannwg University Health Board (ABMU)
Cancer Annual Report Abertawe Bro Morgannwg University Health Board (ABMU) 2015 1 Table of Contents 1.0 Major Developments 2.0 Introduction 3.0 Cancer Incidence, Mortality and Survival in ABMU 3.1 Cancer
More informationBreast Test Wales Screening Division Public Health Wales
Breast Test Wales Screening Division Public Health Wales Programme Level Agreement with Welsh Government Quarterly Report October - December Breast Test Wales - Quarterly Report October - December Service
More informationACE Programme SOMERSET INTEGRATED LUNG CANCER PATHWAY. Phases One and Two Final Report
ACE Programme SOMERSET INTEGRATED LUNG CANCER PATHWAY Phases One and Two Final Report July 2017 Introduction This paper presents the learning and actions that have been generated from phase One and Two
More informationWELCOME AND INTRODUCTIONS. Sarah Tedford Chief Operating Officer Barking, Havering and Redbridge University Hospitals NHS Trust (BHRUT)
WELCOME AND INTRODUCTIONS Sarah Tedford Chief Operating Officer Barking, Havering and Redbridge University Hospitals NHS Trust (BHRUT) ABOUT US OUR COMMUNITY Two main hospital sites King George Hospital
More informationRichard Watson, Chief Transformation Officer. Dr P Holloway, GP Clinical Lead for Cancer Lisa Parrish, Senior Transformation Lead
GOVERNING BODY Agenda Item No. 08 Reference No. IESCCG 18-02 Date. 23 January 2018 Title Lead Chief Officer Author(s) Purpose Cancer Services Update Richard Watson, Chief Transformation Officer Dr P Holloway,
More informationEvaluation of the Integrated Autism Service and Autistic Spectrum Disorder Strategic Action Plan
SOCIAL RESEARCH NUMBER: 13/2018 PUBLICATION DATE: 01/03/2018 Evaluation of the Integrated Autism Service and Autistic Spectrum Disorder Strategic Action Plan Interim Report Mae r ddogfen yma hefyd ar gael
More informationStop Smoking Wales Annual Report
Stop Smoking Wales Annual Report 1 April 2009-31 March 2010 1 Authors: Stop Smoking Wales Editorial Group Date: Annual Report 2009/10 Version: 1 Status: Final Intended Audience: Welsh Assembly Government
More informationCancer Delivery Plan. April Betsi Cadwaladr University Health Board
Cancer Delivery Plan 2015 16 April 2015 Betsi Cadwaladr University Health Board Page 1 of 22 1. Background and context Together for Health a Cancer Delivery Plan was published in 2012 and provides a framework
More informationCommissioning Living with and Beyond Cancer in Yorkshire and Humber; an Overview.
Commissioning Living with and Beyond Cancer in Yorkshire and Humber; an Overview. Document Title An Overview of Commissioning Living with and Beyond Cancer in Yorkshire and Humber Version number: 1 First
More informationHaemato-oncology Clinical Forum. 20 th June 2013
Haemato-oncology Clinical Forum 20 th June 2013 Welcome Dr Majid Kazmi, LCA Haemato-oncology Pathway Group Chair Purpose of today Provide an update on progress of the LCA to date Identify priorities for
More information